We are applying proteomic methodology to unresolved problems in neuropathologic diseases. Methods to identify protein biomarkers of neuropsychiatric disorders, such as the obsessive compulsive syndrome that follows streptococcal infections in pediatric patients are being devised and tested. A combination of immunoaffinity strategies is used to separate proteins from patient sera. Mass spectral patterns of proteins are being compared to determine whether there are statistically significant characteristics of patient state and the disease trait. We have tested several strategies to isolate proteome fractions that are largely free from the most common circulating proteins (albumin, IgG, etc) and are using chemometric analyses to identify variables affecting the reproducibility of the proteome fraction profile using MALDI/TOF measurements of the intact proteins. A second strategy is to isolate proteins implicated from genomic studies as being associated with behavioral diseases. An immunoaffinity strategy based on dysbindin is being devised and tested with available genetically dysbindin-gene modified mouse strains. In collaborative studies with NHGRI, the mitochondrial electron transport complex-I proteomics are being characterized. The hypothesis that deficiency in this complex results in Parkinson?s Disease is being tested. The isolation of patient derived mitochondria is being performed in NHGRI; identification of the gel isolated complex proteins is performed in LNT. In a third series of studies, we have been characterizing post-translational modifications of indoleamine-2,3-dioxygenase (IDO), an enzyme highly activated during CNS inflammation. IDO We investigated whether IDO is affected by peroxynitrite (NO-derived reactive species) using human recombinant IDO (rIDO). The detection of nitrotyrosine by immonoblotting using anti-nitrotyrosine antibody and the measurement of IDO activity in rIDO exposed to various concentrations of peroxynitrite showed that tyrosine (Tyr) residues in rIDO were nitrated and IDO activity was inhibited in a peroxynitrite dose-dependent manner. We are isolating both enzymes over-expressed in E. coli and comparing these primary structures with the same proteins affinity isolated from activated human cells in order to understand the protein regulation and post-translational modifications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH000279-22
Application #
6970024
Study Section
(MH)
Project Start
Project End
Budget Start
Budget End
Support Year
22
Fiscal Year
2004
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Nanavati, Dhaval; Austin, Daniel R; Catapano, Lisa A et al. (2011) The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome. J Neurochem 119:617-29
Harrington, Peter B; Laurent, Claudine; Levinson, Douglas F et al. (2007) Bootstrap classification and point-based feature selection from age-staged mouse cerebellum tissues of matrix assisted laser desorption/ionization mass spectra using a fuzzy rule-building expert system. Anal Chim Acta 599:219-31
Dosemeci, Ayse; Makusky, Anthony J; Jankowska-Stephens, Ewa et al. (2007) Composition of the synaptic PSD-95 complex. Mol Cell Proteomics 6:1749-60
Fujigaki, Hidetsugu; Saito, Kuniaki; Lin, Felix et al. (2006) Nitration and inactivation of IDO by peroxynitrite. J Immunol 176:372-9
Laurent, Claudine; Levinson, Douglas F; Schwartz, Sarah A et al. (2005) Direct profiling of the cerebellum by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: A methodological study in postnatal and adult mouse. J Neurosci Res 81:613-21
Kita, Tomoyuki; Morrison, Paul F; Heyes, Melvyn P et al. (2002) Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem 82:258-68
Jiang, Z G; Piggee, C; Heyes, M P et al. (2001) Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol 117:97-107